Fundraising Fox
Moonlighttx
Founded 2017 · 8 employees on LinkedIn · 2 known investors
Find your way into Moonlighttx
Sign up to see every warm intro you have to Moonlighttx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Moonlighttx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Moonlight Therapeutics is a clinical-stage biotech company developing an intradermal stamp-based immunotherapy for people with food allergies. Its lead therapy, MOON101, targets peanut allergy.
Investors · 2
Related companies · 5
MaplightrxMapLight develops neurological and neuropsychiatric drug therapies using a discovery platform that identifies neural circuits linked to disease for targeted treatment of conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
Luminary TherapeuticsLuminary Therapeutics is a clinical-stage biotech developing allogeneic CAR-T cell therapies built on its Gamma 2.0+ platform to treat solid tumors, B-cell malignancies, and B-cell-mediated autoimmune diseases. The company uses a Dual CAR architecture and the TcBuster transposon system to address relapse, T cell exhaustion, and high manufacturing costs.
QuiverquantQuiver Quantitative scrapes and aggregates alternative stock market data from across the internet into a free web dashboard. It targets retail investors, giving non-professional traders access to alternative data typically reserved for institutional money managers.
Werewolf TherapeuticsWerewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer. The company focuses on leveraging immune modulation and innovative therapeutic approaches in oncology.
Companies working in the same space as Moonlighttx.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $299.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2021 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $651.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Moonlighttx do?
- Moonlight Therapeutics is a clinical-stage biotech company developing an intradermal stamp-based immunotherapy for people with food allergies. Its lead therapy, MOON101, targets peanut allergy.
- Who are Moonlighttx's investors?
- Moonlighttx's investors include Allerfund Ventures, Llc, Portal Innovations.